Skip to main content
Premium Trial:

Request an Annual Quote

Japan-based Softbank to Set Up $120 Million Life Science Fund

NEW YORK, Jan 26 – Tokyo-based Softbank plans to set up a $120 million fund to finance life science companies, a spokeswoman said Friday.

The fund will target companies in the US, Europe, and Asia, beginning in April or May.

Life science companies have much to gain from advances in information technology, said spokeswoman Misao Konishi, citing the role of computing power in the mapping of the human genome.

Softbank has not decided what percentage of the funds will go toward genomics businesses, Konishi said. The fund will invest in both start-ups and more mature companies.

Aozora Bank, which is also in Tokyo, will help finance the project, Konishi said, and other partners are expected to join as the project moves along.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.